Presentation, management and outcome of axillary recurrence from breast cancer

American Journal of Surgery

Volumn 180, Issue 4, 2000, Pages 252-256

  Newman, Lisa A ^a   Hunt, Kelly K ^a   Buchholz, Thomas ^b   Kuerer, Henry M ^a   Vlastos, George ^a   Mirza, Nadeem ^a   Ames, Frederick C ^a   Ross, Merrick I ^a   Singletary, S Eva ^a,b  

^a Department of Surgery ^*  (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; AGED; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MASTECTOMY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; TIME FACTORS; TREATMENT OUTCOME;

EID: 0033653871     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(00)00456-6     Document Type: Conference Paper

References (29)

1. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
2. Impact of axillary lymph node dissection on the therapy of breast cancer patients
3. Does information from axillary dissection change treatment in clinically node-negative patients with breast cancer? An algorithm for assessment of impact of axillary dissection
4. Assessment of morbidity from complete axillary lymph node dissection
5. Arm function after axillary lymph node dissection for breast cancer: A pilot study to provide parameter estimates
6. Axillary lymph node dissection for T1a breast carcinomas: Is it indicated?
7. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma
8. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer
9. The sentinel node in breast cancer: A multicenter validation study
10. Regional nodal failure after conservative surgery and radiotherapy for early stage breast carcinoma
11. Frequency, sites of relapse and outcome of regional nodal failures following conservative surgery and radiation for early breast cancer
12. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation
13. Comparison of radical mastectomy with alternative treatments for primary breast cancer: A first report of results from a prospective randomized trial
14. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast
15. Value of axillary lymph node dissection in addition to lumpectomy and radiotherapy in early breast cancer
16. Patients with early breast cancer benefit from effective axillary treatment
17. Meta-analysis of sentinel lymph node biopsy in breast cancer
18. The Christie Hospital breast conservation trial: An update at 8 years from inception
19. Treatment of the axilla in operable breast cancer
20. Breast cancer: Risk of axillary recurrence in node-negative patients following partial dissection of the axilla
21. Simple mastectomy and axillary node sampling (pectoral node biopsy) in the management of primary breast cancer
22. Breast conservation in elderly women for clinically negative axillary lymph nodes without axillary dissection
23. Conservative treatment of early breast cancer
24. Conservation treatment of early breast cancer: Long-term results and complications
25. Locoregional recurrences following radical external beam irradiation and interstitial implantation for operable breast cancer - A twenty-three year experience
26. Conservative treatment of breast cancer in Europe: Report of the Groupe European de Curietherapie
27. Locoregional failure rates in patients with involved axillary nodes after mastectomy and systemic therapy
28. Postmastectomy radiation therapy: A surgical perspective
29. Lymphatic relapse in women with early breast cancer: A difficult management problem